Items in cart [0] Questions? Call 888-624-8373

PAPERBACK list:$27.00 Web:$24.30 add to cart PDF BOOK your price: $21.00 add to cart Rights & Permissions Free Resources PDF EXECUTIVE SUMMARY Display this book on your site! Related Titles Orphans and Incentives: Developing Technology to Address Emerging Infections Ensuring an Infectious Disease Workforce: Education and Training Needs for the 21st Century - Workshop Summary Other Related Titles Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention, Workshop Summary (2000) Institute of Medicine (IOM) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 97   E-mail  Facebook  Digg  Stumble  Twitter More The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. APPENDIX C Workshop Agenda INSTITUTE OF MEDICINE NATIONAL ACADEMY OF SCIENCES FORUM ON EMERGING INFECTIONS Managed Care Systems and Emerging Infections: Opportunities for Strengthening Surveillance, Research, and Prevention March 23–24, 1998 MONDAY, MARCH 23, 1998 8:00 a.m. Continental Breakfast 8:30 Welcome and Opening Remarks Joshua Lederberg, Ph.D. Chair, Forum on Emerging Infections 8:45 Keynote Address Margaret Hamburg, M.D. Assistant Secretary for Planning and Evaluation U.S. Department of Health and Human Services 9:00–11:00 PANEL I: BASIC AND CLINICAL RESEARCH Moderator: Frederick Sparling, M.D., Forum Member 9:00 AAMC Perspective on Basic and Clinical Research David Korn, M.D. Senior Vice President for Biomedical and Health Science Research Association of American Medical Colleges Page 97 Front Matter (R1-R14) Summary (1-5) 1 Introduction (6-12) 2 Conducting Basic and Clinical Research in the Managed Care Setting (13-24) 3 Clinical Practice Guidelines (25-32) 4 Surveillance and Monitoring (33-51) 5 Education and Outreach (52-61) 6 Drug Formularies (62-75) 7 Concluding Remarks (76-78) References (79-82) Appendix A: Veterans Health Administration and Infectious Disease (83-88) Appendix B: Glossary and Acronyms (89-96) Appendix C: Workshop Agenda (97-102) Appendix D: Forum Member and Staff Biographies (103-114)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 97
Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention, Workshop Summary APPENDIX C Workshop Agenda INSTITUTE OF MEDICINE NATIONAL ACADEMY OF SCIENCES FORUM ON EMERGING INFECTIONS Managed Care Systems and Emerging Infections: Opportunities for Strengthening Surveillance, Research, and Prevention March 23–24, 1998 MONDAY, MARCH 23, 1998 8:00 a.m. Continental Breakfast 8:30 Welcome and Opening Remarks Joshua Lederberg, Ph.D. Chair, Forum on Emerging Infections 8:45 Keynote Address Margaret Hamburg, M.D. Assistant Secretary for Planning and Evaluation U.S. Department of Health and Human Services 9:00–11:00 PANEL I: BASIC AND CLINICAL RESEARCH Moderator: Frederick Sparling, M.D., Forum Member 9:00 AAMC Perspective on Basic and Clinical Research David Korn, M.D. Senior Vice President for Biomedical and Health Science Research Association of American Medical Colleges

OCR for page 98
Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention, Workshop Summary   Opportunities for Population-Based Clinical Research Using Data from Managed Care Organizations Frank DeStefano, M.D., M.P.H. Medical Epidemiologist, Vaccine Safety and Development Activity National Immunization Program, Centers for Disease Control and Prevention   Conducting Clinical Research Within Managed Care Organizations Walter Stamm, M.D. Professor of Medicine and Head, Division of Allergy and Infectious Diseases University of Washington School of Medicine   Clinical Research: The Challenge or Promise of Managed Care Lana Skirboll, Ph.D. Associate Director, Office of Science Policy National Institutes of Health 9:45 Discussion 10:50 Break 11:00 a.m.–1:00 p.m. PANEL II: CLINICAL PRACTICE GUIDELINES Moderator: Vincent Ahonkhai, M.D., Forum Member 11:00 Making Guidelines Instrumental: Theory versus Practice Richard E. Dixon, M.D. Medical Director, National Independent Practice Association Coalition   Realities of Implementing Guidelines Nora Morris, M.A. Assistant Director/Senior Analyst, Healthcare Education and Research Foundation, Inc.   Clinical Practice Guidelines for Emerging Infections and Managed Care Anne Schuchat, M.D. Chief, Childhood and Respiratory Diseases Branch Bacterial and Mycotic Disease Division, National Center for Infectious Diseases Centers for Disease Control and Prevention

OCR for page 99
Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention, Workshop Summary 11:30 Discussion and Working Lunch 1:00–3:00 p.m. PANEL III: SURVEILLANCE AND MONITORING Moderator: Carlos Lopez, Ph.D., Forum Member 1:00 Collaborative Surveillance Efforts and Monitoring of Data Richard Platt, M.D. Director of Research, Harvard Pilgrim Health Care of New England   LDS Hospital's System John Burke, M.D. Department of Clinical Epidemiology, LDS Hospital   An Employer's Perspective Thomas Davies, M.P.A., J.D. Manager of Managed Care, GTE Corporation   Laboratory-Based Reporting and Managing Encounter-Level Data Richard E. Dixon, M.D. Medical Director, National Independent Practice Association   Laboratory-Based Reporting Issues Robert Rubin, M.D. President and Chief Operating Officer The Lewin Group   Surveillance and Monitoring: Issues at the Legal Interface René Bowser, J.D. Georgetown University Law Center   Managed Care and Infectious Disease Surveillance: Opportunities for Collaboration Denise Koo, Ph.D. Director, Division of Public Health Surveillance and Informatics Epidemiology Program Office, Centers for Disease Control and Prevention 1:40 Discussion 2:50 Break

OCR for page 100
Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention, Workshop Summary 3:00–4:30 p.m. PANEL IV: EDUCATION AND OUTREACH Moderator: Renu Gupta, M.D., Forum Member 3:00 Coordinating Health Plan Research and Educational Efforts Richard Platt, M.D. Director of Research, Harvard Pilgrim Health Care of New England   Perspective on Managed Care Systems' Impact on Education and Outreach from the National Center for Infectious Diseases Ben Schwartz, M.D. Deputy Director, Epidemiology and Surveillance Division National Center for Infectious Diseases, Centers for Disease Control and Prevention   Education and Outreach Perspectives by the National Institute of Allergy and Infectious Diseases Karl Western Assistant Director for International Research National Institute of Allergy and Infectious Diseases National Institutes of Health   Managed Care Systems and Emerging Infections: Education and Outreach William Baine, M.D. Center for Cost and Financing Studies Center for Outcomes and Effectiveness Research Agency for Health Care Policy and Research 3:30 Discussion 4:30 Adjournment TUESDAY, MARCH 24, 1998 8:00 a.m. Continental Breakfast 8:30–10:00 a.m. PANEL V: DRUG FORMULARIES Moderator: David Shlaes, M.D., Ph.D., Forum Member

OCR for page 101
Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention, Workshop Summary 8:30 Regulatory Issues Laurie Burke, R.Ph., M.P.H. Chief of Managed Care Outcome and Labeling, Drug Marketing, Advertising, and Communication Division Center for Drug Evaluation and Research U.S. Food and Drug Administration   Relationship Between Managed Care Formularies and Treatment Outcomes Susan Horn, Ph.D. Senior Scientist, Institute for Clinical Outcomes Research Vice President of Research for International Severity Information Systems Professor of Medical Informatics, University of Utah School of Medicine   Bacterial Resistance, the Antibiotic Formulary, and Other Management Strategies Jerome Schentag, Pharm. D. Director, Clinical Pharmacokinetics Laboratory Millard Fillmore Health System Professor of Pharmaceutics and Pharmacy State University of New York at Buffalo   The Economics of Restrictions on Pharmaceuticals Douglas L. Cocks, Ph.D. Senior Research Scientist for Health Economics Eli Lilly & Company 9:00 Discussion 9:50 Break 10:00 a.m.–12:00 noon GENERAL DISCUSSION   General Discussion Moderator: Joshua Lederberg, Ph.D., Forum Chair 10:00 Summary of Sessions by Panel Moderators Panel I: Basic and Clinical Research Frederick Sparling, M.D. Panel II: Clinical Practice Guidelines Vincent Ahonkhai, M.D. Panel III: Surveillance and Monitoring Carlos Lopez, Ph.D. Panel IV: Education and Outreach Renu Gupta, M.D. Panel V: Drug Formularies David Shlaes, M.D., Ph.D.

OCR for page 102
Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention, Workshop Summary 11:00 a.m. Discussion 12:00 noon Closing Remarks Joshua Lederberg, Ph.D. Chair, Forum on Emerging Infections 12:15 p.m. Adjournment

Representative terms from entire chapter:

emerging infections